KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
NKG2-E | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
PRR4 | Proline rich 4 (lacrimal) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BCL2L14 | BCL2-like 14 (apoptosis facilitator) | | | | | | Tissue enhanced |
DUSP16 | Dual specificity phosphatase 16 | Enzymes
| | | | | Expressed in all |
DDX47 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 | Enzymes Plasma proteins
| | | | | Expressed in all |
KIAA1467 | KIAA1467 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATF7IP | Activating transcription factor 7 interacting protein | | | | | | Expressed in all |
HIST4H4 | Histone cluster 4, H4 | Cancer-related genes Disease related genes
| | | | | Mixed |
C12orf60 | Chromosome 12 open reading frame 60 | | | | | | Tissue enhanced |
ERP27 | Endoplasmic reticulum protein 27 | Predicted secreted proteins
| | | | | Tissue enriched |
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
PTPRO | Protein tyrosine phosphatase, receptor type, O | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPS8 | Epidermal growth factor receptor pathway substrate 8 | Disease related genes Plasma proteins
| | | | | Mixed |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
IAPP | Islet amyloid polypeptide | Predicted secreted proteins
| | | | | Tissue enriched |
RECQL | RecQ protein-like (DNA helicase Q1-like) | Enzymes Plasma proteins
| | | | | Expressed in all |
GOLT1B | Golgi transport 1B | Predicted membrane proteins
| | | | | Expressed in all |
LDHB | Lactate dehydrogenase B | Enzymes Plasma proteins
| | | | | Expressed in all |
CMAS | Cytidine monophosphate N-acetylneuraminic acid synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
ST8SIA1 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Mixed |
LRMP | Lymphoid-restricted membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
FGFR1OP2 | FGFR1 oncogene partner 2 | Disease related genes
| | | | | Expressed in all |
PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) | Plasma proteins
| | | | | Expressed in all |
MRPS35 | Mitochondrial ribosomal protein S35 | Mitochondrial proteins
| | | | | Expressed in all |
DNM1L | Dynamin 1-like | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
CNTN1 | Contactin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
YAF2 | YY1 associated factor 2 | | | | | | Expressed in all |
PPHLN1 | Periphilin 1 | | | | | | Expressed in all |
PRICKLE1 | Prickle homolog 1 (Drosophila) | Disease related genes
| | | | | Mixed |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Not detected |
TWF1 | Twinfilin actin-binding protein 1 | | | | | | Expressed in all |
SCAF11 | SR-related CTD-associated factor 11 | | | | | | Expressed in all |
RPAP3 | RNA polymerase II associated protein 3 | | | | | | Expressed in all |
ENDOU | Endonuclease, polyU-specific | Predicted secreted proteins
| | | | | Tissue enhanced |
TMEM106C | Transmembrane protein 106C | Predicted membrane proteins
| | | | | Expressed in all |
SENP1 | SUMO1/sentrin specific peptidase 1 | Enzymes
| | | | | Expressed in all |
ASB8 | Ankyrin repeat and SOCS box containing 8 | | | | | | Expressed in all |
CCNT1 | Cyclin T1 | Plasma proteins
| | | | | Expressed in all |
FKBP11 | FK506 binding protein 11, 19 kDa | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TUBA1B | Tubulin, alpha 1b | | | | | | Expressed in all |
TUBA1A | Tubulin, alpha 1a | Cancer-related genes Disease related genes FDA approved drug targets
| | | | | Expressed in all |
PRPH | Peripherin | | | | | | Tissue enhanced |
MCRS1 | Microspherule protein 1 | Plasma proteins
| | | | | Expressed in all |
PRPF40B | PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae) | | | | | | Expressed in all |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Group enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RACGAP1 | Rac GTPase activating protein 1 | | | | | | Expressed in all |